Gene: CDKN2A ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 AlteredExpression disease BEFREE Consistent with this notion, re-instatement of constitutive p19ARF expression in the HB model completely suppressed tumorigenesis. 28820908 2017
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 Biomarker disease RGD Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. 16317707 2005
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 GeneticVariation disease BEFREE Aberrant methylation of 5' CpG islands of p16 was present in 12 of 24 (50.0%) cases of hepatoblastoma. 12748249 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 Biomarker disease RGD De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. 12359353 2002
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 Biomarker disease RGD Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. 11301474 2001
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.230 GeneticVariation disease BEFREE These results show that CDKN2A gene family alterations are not involved in hepatoblastoma development, whereas changes in cyclin D types might play a role in this type of tumor. 9537438 1998